Gemma Brown - 15 Sep 2022 Form 3 Insider Report for Vaccitech plc (BRNS)

Role
Chief Financial Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
3
Filing time
23 Sep 2022, 16:05:21 UTC
Next filing
28 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VACC Share Option (Right to Buy) 15 Sep 2022 Ordinary Shares 30,900 $14.96 Direct F1, F2
holding VACC Share Option (Right to Buy) 15 Sep 2022 Ordinary Shares 7,499 $11.12 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment having vested on September 6, 2022.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023.

Remarks:

Exhibit 24 - Power of Attorney